MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.
Molekulargewicht:
495.38
Reinheit:
99.39%
CAS Nummer:
[2803881-11-8]
Formel:
C22H17F4N3O6
Target-Kategorie:
Apoptosis|||Others
T67934
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten